These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 9147612)
1. Activation of the retinoic acid receptor beta gene by 5-aza-2'-deoxycytidine in human DLD-1 colon carcinoma cells. Côté S; Momparler RL Anticancer Drugs; 1997 Jan; 8(1):56-61. PubMed ID: 9147612 [TBL] [Abstract][Full Text] [Related]
2. Demethylation by 5-aza-2'-deoxycytidine of specific 5-methylcytosine sites in the promoter region of the retinoic acid receptor beta gene in human colon carcinoma cells. Côté S; Sinnett D; Momparler RL Anticancer Drugs; 1998 Oct; 9(9):743-50. PubMed ID: 9840718 [TBL] [Abstract][Full Text] [Related]
3. Antineoplastic action of 5-aza-2'-deoxycytidine and histone deacetylase inhibitor and their effect on the expression of retinoic acid receptor beta and estrogen receptor alpha genes in breast carcinoma cells. Bovenzi V; Momparler RL Cancer Chemother Pharmacol; 2001 Jul; 48(1):71-6. PubMed ID: 11488527 [TBL] [Abstract][Full Text] [Related]
4. DNA methylation of retinoic acid receptor beta in breast cancer and possible therapeutic role of 5-aza-2'-deoxycytidine. Bovenzi V; Lê NL; Côte S; Sinnett D; Momparler LF; Momparler RL Anticancer Drugs; 1999 Jun; 10(5):471-6. PubMed ID: 10477167 [TBL] [Abstract][Full Text] [Related]
5. Quantitation of inhibition of DNA methylation of the retinoic acid receptor beta gene by 5-Aza-2'-deoxycytidine in tumor cells using a single-nucleotide primer extension assay. Bovenzi V; Momparler RL Anal Biochem; 2000 May; 281(1):55-61. PubMed ID: 10847610 [TBL] [Abstract][Full Text] [Related]
6. 5-aza-2'-deoxycytidine induces retinoic acid receptor beta 2 demethylation, cell cycle arrest and growth inhibition in breast carcinoma cells. Yang Q; Shan L; Yoshimura G; Nakamura M; Nakamura Y; Suzuma T; Umemura T; Mori I; Sakurai T; Kakudo K Anticancer Res; 2002; 22(5):2753-6. PubMed ID: 12529992 [TBL] [Abstract][Full Text] [Related]
7. Hypermethylation and silencing of the putative tumor suppressor Tazarotene-induced gene 1 in human cancers. Youssef EM; Chen XQ; Higuchi E; Kondo Y; Garcia-Manero G; Lotan R; Issa JP Cancer Res; 2004 Apr; 64(7):2411-7. PubMed ID: 15059893 [TBL] [Abstract][Full Text] [Related]
9. 5-Aza-2'-deoxycytidine induces retinoic acid receptor-beta(2) demethylation and growth inhibition in esophageal squamous carcinoma cells. Liu Z; Zhang L; Ding F; Li J; Guo M; Li W; Wang Y; Yu Z; Zhan Q; Wu M; Liu Z Cancer Lett; 2005 Dec; 230(2):271-83. PubMed ID: 16297713 [TBL] [Abstract][Full Text] [Related]
10. Retinoic acid receptor-β gene reexpression and biological activity in SHI-1 cells after combined treatment with 5-aza-2'-deoxycytidine and all-trans retinoic acid. Xiang L; Wang R; Wei J; Qiu G; Cen J; Hu S; Xie X; Chen Z; Gu W Acta Haematol; 2015; 133(3):279-86. PubMed ID: 25413479 [TBL] [Abstract][Full Text] [Related]
11. Interaction of 5-aza-2'-deoxycytidine and depsipeptide on antineoplastic activity and activation of 14-3-3sigma, E-cadherin and tissue inhibitor of metalloproteinase 3 expression in human breast carcinoma cells. Gagnon J; Shaker S; Primeau M; Hurtubise A; Momparler RL Anticancer Drugs; 2003 Mar; 14(3):193-202. PubMed ID: 12634613 [TBL] [Abstract][Full Text] [Related]
12. Pharmacological approach for optimization of the dose schedule of 5-Aza-2'-deoxycytidine (Decitabine) for the therapy of leukemia. Momparler RL; Côté S; Eliopoulos N Leukemia; 1997 Feb; 11(2):175-80. PubMed ID: 9009076 [TBL] [Abstract][Full Text] [Related]
13. Pharmacological approach for optimization of the dose schedule of 5-Aza-2'-deoxycytidine (Decitabine) for the therapy of leukemia. Momparler RL; Côté S; Eliopoulos N Leukemia; 1997 Mar; 11 Suppl 1():S1-6. PubMed ID: 9130684 [TBL] [Abstract][Full Text] [Related]
14. Activation of the p53 DNA damage response pathway after inhibition of DNA methyltransferase by 5-aza-2'-deoxycytidine. Karpf AR; Moore BC; Ririe TO; Jones DA Mol Pharmacol; 2001 Apr; 59(4):751-7. PubMed ID: 11259619 [TBL] [Abstract][Full Text] [Related]
15. Hyperacetylation enhances the growth-inhibitory effect of all-trans retinoic acid by the restoration of retinoic acid receptor beta expression in head and neck squamous carcinoma (HNSCC) cells. Whang YM; Choi EJ; Seo JH; Kim JS; Yoo YD; Kim YH Cancer Chemother Pharmacol; 2005 Nov; 56(5):543-55. PubMed ID: 15959780 [TBL] [Abstract][Full Text] [Related]
16. Hypermethylation of the retinoic acid receptor-beta(2) gene in head and neck carcinogenesis. Youssef EM; Lotan D; Issa JP; Wakasa K; Fan YH; Mao L; Hassan K; Feng L; Lee JJ; Lippman SM; Hong WK; Lotan R Clin Cancer Res; 2004 Mar; 10(5):1733-42. PubMed ID: 15014026 [TBL] [Abstract][Full Text] [Related]
17. Hypomethylation of the metastasis-associated S100A4 gene correlates with gene activation in human colon adenocarcinoma cell lines. Nakamura N; Takenaga K Clin Exp Metastasis; 1998 Jul; 16(5):471-9. PubMed ID: 10091942 [TBL] [Abstract][Full Text] [Related]
18. Regulation of demethylation and re-expression of RASSF1A gene in gastric cancer cell lines by combined treatment of 5-Aza-CdR and NaB. Shen WJ; Dai DQ; Teng Y; Liu HB World J Gastroenterol; 2008 Jan; 14(4):595-600. PubMed ID: 18203293 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of the antineoplastic activity of adozelesin alone and in combination with 5-aza-2'-deoxycytidine and cytosine arabinoside on DLD-1 human colon carcinoma cells. Côté S; Momparler RL Anticancer Drugs; 1993 Jun; 4(3):327-33. PubMed ID: 7689364 [TBL] [Abstract][Full Text] [Related]
20. Microarray analysis of gene expression in metastatic gastric cancer cells after incubation with the methylation inhibitor 5-aza-2'-deoxycytidine. Chen J; Röcken C; Klein-Hitpass L; Götze T; Leodolter A; Malfertheiner P; Ebert MP Clin Exp Metastasis; 2004; 21(5):389-97. PubMed ID: 15672863 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]